Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding TSE:HHL?
Track your performance easily
TSE:HHL Price & Analysis
HHL ETF Chart & Stats
Day’s Range― - ―
52-Week RangeC$7.63 - C$8.95
Previous CloseC$7.65
VolumeN/A
Average Volume (3M)183.16K
AUM1.35B
NAV7.67
Expense Ratio1.06%
Holdings Count24
Beta0.47
Inception DateNov 19, 2014
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard Deviation0.04
10 Day Avg. Volume230,017
30 Day Avg. Volume183,165
Alpha0.00382
Healthcare LdrIncmUn (HHL) Fund Flow Chart
Healthcare LdrIncmUn (HHL) 1 year Net Flows: C$55M
HHL ETF News
HHL ETF FAQ
What was TSE:HHL’s price range in the past 12 months?
TSE:HHL lowest ETF price was C$7.63 and its highest was C$8.95 in the past 12 months.
What is the AUM of TSE:HHL?
As of Dec 18, 2024 The AUM of TSE:HHL is 1.35B.
Is TSE:HHL overvalued?
According to Wall Street analysts TSE:HHL’s price is currently Undervalued.
Does TSE:HHL pay dividends?
TSE:HHL does not currently pay dividends.
How many shares outstanding does TSE:HHL have?
Currently, no data Available
Which hedge fund is a major shareholder of TSE:HHL?
Currently, no hedge funds are holding shares in TSE:HHL
HHL ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Boston Scientific
5.33%
Abbott Laboratories
5.33%
Agilent Technologies
5.21%
Abbvie
5.20%
Eli Lilly And Company
5.17%
Merck & Company
5.13%
Thermo Fisher Scientific
5.10%
Amgen Inc
5.08%
Danaher Corporation
5.06%
AstraZeneca
5.01%
Total51.62%
ETF Description
Healthcare LdrIncmUn
The fund invests in an equally weighted portfolio of 20 North American healthcare companies, with a covered call overlay for monthly income.